Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Open accessThe DOI matches its Crossref record; 198 of the 200 references it cites were found in a registry or an index.
Abstract
The blood–brain barrier (BBB) keeps neurotoxic plasma-derived components, cells, and pathogens out of the brain. An early BBB breakdown and/or dysfunction have been shown in Alzheimer’s disease (AD) before dementia, neurodegeneration and/or brain atrophy occur. However, the role of BBB breakdown in neurodegenerative disorders is still not fully understood. Here, we examine BBB breakdown in animal models frequently used to study the pathophysiology of AD, including transgenic mice expressing human amyloid-β precursor protein, presenilin 1, and tau mutations, and apolipoprotein E, the strongest genetic risk factor for AD. We discuss the role of BBB breakdown and dysfunction in neurodegenerative process, pitfalls in BBB measurements, and how targeting the BBB can influence the course of neurological disorder. Finally, we comment on future approaches and models to better define, at the cellular and molecular level, the underlying mechanisms between BBB breakdown and neurodegeneration as a basis for developing new therapies for BBB repair to control neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CAA is caused by A 𝛃 deposition in the vascular wall of small brain arteries and capillaries and develops as a result of an imbalance between A 𝛃 production and clearance, particularly faulty transvascular and perivascular clearance of A 𝛃 from the brain (318, 420, 581, 640).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, microvascular endothelial aging also disrupts the blood-brain barrier, which promotes neuroinflammation, exacerbating cognitive decline”
From Single-cell RNA sequencing identifies senescent cerebromicrovascular endothelial cells in the aged mouse brain (2020) · cites this paper as Montagne et al. 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of claudins is associated with BBB breakdown in human neurodegenerative disorders (155, 569) and acute CNS diseases (692), as well as in animal models of these diseases (420), as discussed below.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As previously reviewed, FDG-PET reflects mainly the transport activity of GLUT1 BBB transporter (420, 569).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides FDG-PET and verapamil-PET that have been used to test functions of BBB GLUT1 transporter and activity of ABCB1 (P-gp) efflux transporter in AD and PD (420, 569), respectively”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [420]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
Self-citationRetractedSokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000 · cited 6×
“…for glucose-6-phosphate isomerase and therefore cannot be converted into fructose-6-phosphate, a necessary step to enter the glycolytic pathway or Krebs cycle, as shown by multiple independent studies (Sols and Crane, 1954; Sokoloff et al., 1977; McDougal et al., 1990; Rokka et al., 2017).”
BackgroundInfluentialIliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544 · cited 13×
“…in APPSw/0 mice (at 1, 3, and 6 mo of age; Ujiie et al., 2003; Paul et al., 2007; Sagare et al., 2013) before Aβ deposition, cerebral amyloid angiopathy (CAA), and/or behavioral deficits that develop later (at 7–10, 9–12, and 6–9 mo of age, respectively; Domnitz et al., 2005; Webster et al., 2014).”
BackgroundInfluentialSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 1×
“Because of minimal glucose-6-phosphatase activity in the brain (Hers and De Duve, 1950; Sokoloff et al., 1977) and low 2DG-6P membrane permeability, 2DG-6P remains trapped in brain cells (Huang and Veech, 1985; Southworth et al., 2003) and is eliminated very slowly from the brain.”
BackgroundClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · cited 2×
“, 2001; Armstrong, 2008) and imaging studies in the living human brain (Bateman et al., 2012; Benzinger et al., 2013; Fleisher et al., 2015), respectively.”
BackgroundOakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“…et al., 2002; Zipser et al., 2007; Hultman et al., 2013; Zonneveld et al., 2014; Halliday et al., 2016), diminished regional BBB uptake of glucose (Ossenkoppele et al., 2013; Protas et al., 2013), and early neurovascular dysfunction (Rei- man et al., 2004; Sheline et al., 2010; Thambisetty et…”
BackgroundHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 1×
“3157JEM Vol. 214, No. 11 (PIC ALM) protein encoded by the PIC ALM gene, a highly validated genetic risk factor for human AD (Harold et al., 2009; Lambert et al., 2009; Huang et al., 2017), accelerates Aβ deposition in APPSw/0 mice, consistent with its critical role in regulating LRP1-mediated Aβ…”
Research works printed but not linked: 2
- Hachinski, 2016, Correction. World Stroke Organization. Stroke and potentially preventable dementias proclamation: updated World Stroke Day proclamation, Stroke., 47, e37
- Holtzman, 2000, Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model, Ann. Neurol., 47, 739, 10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8 · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8
Cited by
Items 501–600 of 688
Bowirrat, A., Pinhasov, A., Bowirrat, A., & Badgaiyan, R. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178253 · Cited by 8
“It was shown that changes in the BBB’s permeability are implicated in the pathophysiology of neurodegenerative diseases, including AD, by facilitating neuroinflammation through unregulated protein entry [23,62].”
Li, W., Han, Y., Wang, P., & Qiao, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70803 · Cited by 7
“152 155 Damaged BBB, in turn, pro-motestheaccumulationofADpathologyandacceleratesbraincellular senescence, thus driving the vicious cycle between AD pathology and cellular senescence.”
InfluentialOgata, S., Ito, S., Masuda, T., & Ohtsuki, S. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00609-6 · Cited by 6
“For instance, BBB breakdown is observed in Alzheimer’s disease (AD), even before the appearance of dementia symptoms [1] Additionally, impairment of the basement membrane in brain capillaries has been observed in AD model mice [2].”
Jiang, F., Wang, N., & Meng, Q. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360321 · Cited by 6
“122,123 Moreover, advanced glycation end products (AGEs) induce phosphorylation of moesin — a cytoskeletal linker protein belonging to the ERM (ezrin-radixin-moesin) protein family — through activation of the RhoA/ROCK and p38 signaling pathways.”
WP1234—A Novel Anticancer Agent with Bifunctional Activity in a Glioblastoma Model
Pająk, B., SİWİAK, E., Jaśkiewicz, A., Sołtyka, M., & Domoradzki, T. (2022) · Biomedicines · doi:10.3390/biomedicines10112799 · Cited by 6
“Our attention has been focused on small molecules that are able to penetrate the BBB. 2-DG is an analog of glucose and is transported across the BBB by the glucose carrier system, mainly glucose transporter 1 (GLUT1) [8].”
BackgroundThe role of SUMOylation in the neurovascular dysfunction after acquired brain injury
Luo, P., Li, L., Huang, J., Mao, D., Lou, S., Ruan, J., Chen, J., Tang, R., Shi, Y., Zhou, S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125662 · Cited by 6
“ABI can cause BBB damage, and various components in the blood will invade the brain tissue, resulting in cell infiltration and damage (Zhao et al., 2015; Montagne et al., 2017).”
BackgroundZhang, L., Zhu, B., Zhou, X., Hao, N., Zhang, F., Yan, B., Chen, J., & Ma, T. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00693-4 · Cited by 6
“Therefore, BBB integrity is highly relevant to AD, and interventions that maintain optimal BBB function are important to consider when treating or preventing the onset of AD (Montagne et al. 2017).”
Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics
Sun, J., & Song, S. (2024) · Microfluidics and Nanofluidics · doi:10.1007/s10404-024-02741-z · Cited by 6
[Relationship between Oral Microbiota and Alzheimer's Disease].
Li, Y.-C., Liu, Y., Chen, F., Chu, M., & Chen, X.-C. (2022) · 四川大学学报:医学版 · doi:10.12182/20220360304 · Cited by 7
Längrich, T., Bork, K., Horstkorte, R., Weber, V., Hofmann, B., Fuszard, M., & Olzscha, H. (2022) · Proteomes · doi:10.3390/proteomes10030028 · Cited by 6
“It ensures that both endogenous substances and cells as well as exogenous substances and cells such as drugs or pathogens are prevented from entering the brain [1].”
BackgroundEl populismo: de intruso a problema relevante para la ciencia social
Sáez, A. R. (2018) · Revista Internacional de Sociología · doi:10.3989/ris.2018.76.4.18.076 · Cited by 7
Age-Related Decline in BBB Function is More Pronounced in Males than FemalesPreprint
Shao, X., Shou, Q., Felix, K., Ojogho, B., Jiang, X., Gold, B. T., Herting, M. M., Goldwaser, E. L., Kochunov, P., Hong, L. E., et al. (2024) · eLife · doi:10.7554/elife.96155.1 · Cited by 6
Photoacoustic imaging detects cerebrovascular pathological changes in sepsis
Wang, Z., Ai, C., Sun, T., Wang, Z., Zhang, W., Zhou, F., & Wu, S. (2025) · Photoacoustics · doi:10.1016/j.pacs.2025.100737 · Cited by 7
Measurement and Modeling of Transport Across the Blood–Brain Barrier
Fan, H., Cai, Q., & Qin, Z. (2023) · Journal of Biomechanical Engineering · doi:10.1115/1.4062737 · Cited by 6
Lee, S., Kim, S. E., Jang, H., Kim, J. P., Sohn, G., Park, Y. H., Ham, H., Gu, Y., Park, C. J., Kim, H. J., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01483-y · Cited by 5
“Our finding might be explained by several hypotheses including ischemia-induced activation of cyclin-dependent kinase 5 (CDK-5) and glycogen synthase kinase 3β (GSK-3β), eventually resulting in the hyperphosphorylation of tau [61, 62].”
BackgroundMicrovessel isolation protocol for RNA visualization and profiling
Naranjo, O., Osborne, O., Torices, S., Schmidlin, S., Tiburcio, D., Park, M., & Toborek, M. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-77501-8 · Cited by 5
Festoff, B. W., & Dockendorff, C. (2021) · Biomolecules · doi:10.3390/biom11111558 · Cited by 5
Bei, J., Qiu, Y., Cockrell, D. C., Chang, Q., Husseinzadeh, S., Zhou, C., Fang, X., Bao, X., Jin, Y., Gaitas, A., et al. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31061 · Cited by 5
“macromolecules and is attributed to junction tightness and limited transcytosis of specific molecules by transporter/receptor‐mediated transcytosis (Montagne et al., 2017; Sweeney et al., 2018).”
BackgroundMicronutrients for Natural Carbonated and Noncarbonated Soft Drink
Azim, A. A. S. A. (2017) · Journal of Nutritional Health & Food Engineering · doi:10.15406/jnhfe.2017.07.00226 · Cited by 5
Androuin, A., Abada, Y.-S. K., Ly, M., Santin, M. D., Petiet, A., Epelbaum, S., Bertrand, A., & Delatour, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37980-y · Cited by 5
Pilozzi, A. R., Carro, C., Whalen, M. J., & Huang, X. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch8 · Cited by 9
“The presence of immune cells derived from main circulation, such as peripheral macrophages, neutrophils, and leukocytes, in the brain is an indication of BBB breakdown (18).”
BackgroundZhao, W., Zhao, Y., Ming, L., Liu, L., & Wang, Y. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06741-y · Cited by 5
Spampinato, S. F., Takeshita, Y., & Obermeier, B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_20 · Cited by 5
Single Nuclei Transcriptome Reveals Perturbed Brain Vascular Molecules in Alzheimer’s DiseasePreprint
İş, Ö., Wang, X., Patel, T., Quicksall, Z., Heckman, M. G., White, L. J., Lewis‐Tuffin, L. J., Deniz, K., Tutor‐New, F. Q., Carnwath, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.28.474255 · Cited by 5
Cai, M., Chen, S., Du, Y., Li, S., Dong, P., Wang, L., Yang, R., Hu, J., & Zhu, L. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02052-4 · Cited by 4
“Previous studies have reported that BBB dysfunction may cause the accumulation of harmful component and generate a vicious loop between brain Aβ buildup and neurovascular unit deficits, consequently, resulting in neurological dysfunction (Cai et al. 2018; Montagne et al. 2017; Rajeev et al. 2022).”
BackgroundYue, Q., Li, S., Lei, C. L., Wan, H., Zhang, Z., & Hoi, M. P. M. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00695 · Cited by 4
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
Ma, J., Yang, B., Jiang, X., Wang, L., Wei, W., Cao, Y., & Li, H. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113177 · Cited by 4
Fu, W., Lu, R., Wang, D., & Sang, Z. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110044 · Cited by 4
Denkinger, M. N., Baker, S. L., Harrison, T. M., Chadwick, T. A., & Jagust, W. J. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.11.002 · Cited by 4
“Conversely, there is evidence suggesting that the overproduction and accumulation of A β itself can compromise the integrity of the BBB (Montagne et al., 2017), indicating a potential bidirectional relationship between these pathological processes.”
Sun, J., Shao, X., Wang, X. L., Yin, X., Qiu, W., Qian, X., Liu, F., Chen, Y., & Ma, C. (2025) · Molecular Brain · doi:10.1186/s13041-025-01226-6 · Cited by 4
Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors
Mortezaei, N. T., Habibzadeh, A., Rahimian, Z., Boushehri, S., Pourbakhtyaran, E., Savoji, A. B., & Farid, A. S. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_400 · Cited by 4
Wnt-Regulated Therapeutics for Blood-Brain Barrier Modulation and Cancer Therapy
An, P., Tong, Y., Mu, R., & Han, L. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00537 · Cited by 4
Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia
Chiu, Y., Xia, S., Qiao, H., & Zhao, Z. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.11.006 · Cited by 6
Self-citationTwo-Photon Phosphorescence Lifetime Microscopy
Abbasizadeh, N., & Spencer, J. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-7627-0_4 · Cited by 4
Коваленко, Е. А., Makhnovich, E. V., Osinovskaya, N. A., & Bogolepova, A. N. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212210138 · Cited by 4
Liu, Y., Chang, D., Liu, T., & Zhou, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1135934 · Cited by 9
Chen, Y., Zhao, S., Basu, S., Shi, J. F., Song, K., Siripun, P., Huynh, H., Zhao, Y., & Campbell, R. H. (2024) · Research Square · doi:10.21203/rs.3.rs-4754944/v1 · Cited by 4
Wei, H., Zhang, G., Xu, Y., Zhao, A., Zheng, Y., Shao, Y. W., Yang, L., Wang, J., & Jiang, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157238 · Cited by 4
Yu, Y., Yu, J.-J., Ding, S., Zhang, G., Liu, Y., Guo, R., Zang, J., Zhao, X.-X., Li, X., & Kong, L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103055 · Cited by 4
“…therapeutic application of such multi-target agents is severely constrained by poor blood-brain barrier (BBB) penetration, insufficient cellular specificity, and rapid systemic clearance, under-scoring the critical need for precise co-delivery strategies within the central nervous system [23 – 25].”
Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers
Sagare, A. P., Lohman, T., Ramirez, I., Joe, E., Harrington, M. G., Chui, H. C., Schneider, L. S. S., Yassine, H. N., Ringman, J. M., Toga, A. W., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02291-y · Cited by 3
Dhar, I., Bhatt, S., Gupta, S., Singh, S. K., & Dadhich, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100557 · Cited by 4
Sarlus, H., Codita, A., Wang, X., Cedazo-Mínguez, Á., Schultzberg, M., & Oprica, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.005 · Cited by 3
“…partly explain the increased load of immunoglobulins in the brains of salinetreated 3xTgAD mice, given that IgG can potentially cross the blood brain barrier (BBB) through a saturable trans- porter (Zlokovic et al., 1990; St-Amour et al., 2013) or a compromised BBB in AD (Montagne et al., 2017).”
BackgroundJoseph, C. R., Melin, D., Wanner, L. K., Hartman, B., Badelita, J., Conser, L., Kline, H., Pradhan, P., & Love, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115040 · Cited by 3
“Why does that natural recovery pathway diminish with age [67,69]?”
Alzheimer Dementia and Microvascular Pathology: Blood-Brain Barrier Permeability Imaging
Moon, W. (2020) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2020.81.3.488 · Cited by 5
“알츠하이머 치매병리에는 BBB의 구조적 파괴와 BBB 기능조절장애의 두 가지 기전이 역할을 한다 (4).”
InfluentialDutta, R. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001035 · Cited by 4
“This heavy restriction allows endothelial cells of BBB to tightly regulate CNS homeostasis, required for proper neuronal function, as well as protect the CNS from toxins, pathogens, in lammation, injury, and disease [3].”
BackgroundImmunotherapeutics for AD: A Work in Progress
Sharma, A., Anand, J. S., & Kumar, Y. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210903101522 · Cited by 4
Al-Ahmad, A. J. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_645 · Cited by 3
McLarnon, J. G. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230912113501 · Cited by 3
Drapaca, C. S. (2024) · Fractal and Fractional · doi:10.3390/fractalfract8090496 · Cited by 4
Drapaca, C. S. (2024) · Mathematical and Computational Applications · doi:10.3390/mca29060117 · Cited by 4
“On the other hand, AD causes the disintegration of the blood-brain barrier that further leads to impaired diffusion and interstitial fluid flow within the cerebral extracellular space, enhanced cerebral inflammatory and immune responses, progression of AD, and, potentially, strokes [4,90,91].”
Wei, Z., Liu, C., Chen, J., Yao, Y., & Qin, D. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70015 · Cited by 3
Blood-Brain Barrier Function as a Biomarker in Toxicology: Impact of Environmental Toxicants
Kelly, G., Watase, C. K., & Ho, D. H. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87225-0_36-1 · Cited by 3
Yang, X., Luo, Y., Wang, T., Wang, M.-X., LU, W., Zeng, H.-L., & Wu, D. (2025) · Brain and Behavior · doi:10.1002/brb3.71143 · Cited by 2
“Beyond structural damage, BBB leakage allows neurotoxic solutes to accumulate in the parenchyma, provoking mitochondrial failure, synaptic loss, and erosion of cognitive reserve (Montagne et al. 2017 ; Nakhaee et al. 2024 ).”
Wu, Y., Li, P., Liu, L., Fan, H., & Liu, M. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.01.040 · Cited by 2
Zhai, Y., Nevian, T., Finn, D. P., & Kwakowsky, A. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00025-0 · Cited by 2
Bay, C., Mühlberg, E., Uhl, P., Stingl, J., Bajraktari‐Sylejmani, G., Burhenne, J., Weiß, J., & Sauter, M. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00806-5 · Cited by 2
Bhukta, P., Sahu, P. K., & Acharya, B. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100495 · Cited by 2
Soluble epoxide hydrolase drives neurovascular dysfunction in a model of amyloidosis
DeMeglio, M., Biasi, E. S. D., Breunig, P., Candlish, M., Sauerland, C., Günther, S., Kawase, H., Peguera, B., Bohnstaedt, C., Herms, J. W., et al. (2026) · Brain · doi:10.1093/brain/awag184 · Cited by 2
Jiang, S., Yu, L., Yang, H., Jin, Y., Chen, J., Zhang, J., Liu, Y., & Xu, Y. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.99427 · Cited by 2
Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
Ferré‐González, L., Peña‐Bautista, C., Álvarez‐Sánchez, L., Ferrer, I., Baquero, M., & Cháfer‐Pericás, C. (2021) · Antioxidants · doi:10.3390/antiox10111662 · Cited by 2
“Biomarkers of lipid peroxidation in the brain have been linked to histological lesions produced in neurodegenerative diseases, such as β-amyloid plaques [25].”
BackgroundBhattacharya, K., Sungoh, D., Kharmujai, D., Islam, A. F. M. M., Das, D., Jha, S. K., Chanu, N. R., Kashyap, B., Bora, N. S., Sahariah, B. J., et al. (2024) · Current Alzheimer Research · doi:10.2174/0115672050358848241211080546 · Cited by 2
New Research on Biomarkers in Alzheimer’s Continuum
Vecchio, I., & Colica, C. (2025) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871331138250114052615 · Cited by 3
Qiu, H., Zhang, M., Chen, C., Wang, H., & Yue, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041514 · Cited by 4
“Cerebrovas-cular endothelial cells are crucial components in the formation of BBB, accounting for over 85% of cerebrovascular length and playing an indispensable role as selective permeability barriers [29].”
Treating early dementia: Drug targeting and circumventing the blood-brain barrier
D'Arrigo, J. S. (2018) · Geriatric Medicine and Care · doi:10.15761/gmc.1000111 · Cited by 2
“An early BBB breakdown and/or dysfunction has been documented [92] in Alzheimer’s disease before dementia, neurodegeneration, and/or brain atrophy occur, and investigators have reported that targeting the BBB can influence the course of neurological disorder [92].”
Vascular Dysfunction and Neurodegenerative Disease
Gao, Z., Cilento, E. M., Stewart, T., & Zhang, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-25249-6_1 · Cited by 2
Li, Z., Ip, B. Y. M., Mok, V., & Ko, H. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.313042 · Cited by 2
“…in a human mutant amyloid precursor protein-based model AD model which typically does not develop tauopathy, heterozygous Pdgfrb (platelet-derived growth factor receptor β) deletion-induced pericyte loss and vascular deficits led to tau hyperphosphorylation and deposition (Montagne et al., 2017).”
The Therapeutic Potential of Focused Ultrasound in Patients with Alzheimer’s Disease
Коваленко, Е. А., Makhnovich, E. V., Osinovskaya, N. A., & Bogolepova, A. N. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01471-z · Cited by 3
“On the one hand, some authors have described high BBB permeability as an early sign of AD [9, 10].”
BackgroundThe Alzheimer risk factor CD2AP causes dysfunction of the brain vascular networkPreprint
Vandal, M., Institóris, Á., Korin, B., Gunn, C., Lee, S., Lee, J. Y., Bourassa, P., Mishra, R. C., Peringod, G., Jiang, Y., et al. (2020) · Research Square · doi:10.1101/2020.12.10.419598 · Cited by 2
Neuronally differentiated endothelial cell subtype regulates organ blood flow and immune balancePreprint
Gyarmati, G., Rust, R., Calderon, A. B., Izuhara, A. K., Trogen, G. H., Deepak, S. K., Chen, Y., Ruffins, S. W., Junge, J. A., Zloković, B. V., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.30.615824 · Cited by 2
“BBB endothelial dysfunction can lead to Alzheimer disease, epilepsy, and multiple sclerosis 13-15 .”
BackgroundThe bidirectional links between coronavirus disease 2019 and Alzheimer’s disease
Nouraeinejad, A. (2024) · International Journal of Neuroscience · doi:10.1080/00207454.2024.2327403 · Cited by 1
Hotta, K., Shimotsu, R., Behnke, B. J., Masamoto, K., Yagishita, K., Poole, D. C., & Kano, Y. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00222.2024 · Cited by 2
An Overview of the Blood-Brain Barrier
Barichello, T., Generoso, J. S., & Dal‐Pizzol, F. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_1 · Cited by 1
Embalabala, R., Masters, H., Ziehm, E. M., Pouncey, J., Kim, H., & Lippmann, E. S. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00766-w · Cited by 1
“…believed to occur relatively early in Alzheimer’s disease (AD), before the onset of dementia, rendering such changes as potential targets for therapeutic intervention [7–10]; as such, a key consideration for understanding these changes is their proper representation in experimental model systems.”
Rao, A. R., Pradhan, R., Anwar, M., Gupta, A., Bhagwasia, M., Nichols, E., Gross, A. L., Thyagarajan, B., Hu, P., Crimmins, E. M., et al. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70336 · Cited by 1
“While this response may initially be protective, chronic astrocyte reactivity can break down the blood–brain barrier, impair synaptic plasticity, and contribute to neuronal loss—key features of conditions like Alzheimer's disease [26, 27].”
On consciousness in animals and in artificial intelligence
Arshavsky, Y. I. (2026) · Journal of Neurophysiology · doi:10.1152/jn.00019.2026 · Cited by 1
Salunkhe, D. S., Nangare, S., Jadhav, N. R., Tade, R. S., Desai, A., & Vihal, S. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151872 · Cited by 2
Friend or foe? Glial–vascular interactions in health and neurodegenerative disease
McQuaid, C., Sewell, M. D. E., & Montagne, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100143 · Cited by 1
“33 Per-icytes also play an essential role in maintaining BBB integrity from early developmental stages, 34 partly by releasing signaling molecules that regulate permeability and support vascular development and maturation.”
Self-citationKumari, N., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., & HariKrishnaReddy, D. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118107 · Cited by 1
Zhang, Y., Lee, J.-H., Yu, Z.-F., Tao, Y., Rimal, S., He, Y., Lv, L., Lu, B., & Ping, Y. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2530907123 · Cited by 1
Autophagy in Alzheimer’s Disease: Mechanisms, Clinical Trials, and Horizons
Tshimbombu, T. N., Thurmann, K. E., Decourt, B., Nyalundja, A. D., Shardow, S. B., Amoako, M. E., Gates, I., Aganze, J. M., & Sabbagh, M. N. (2026) · Neurodegenerative Diseases · doi:10.1159/000553506 · Cited by 1
Yang, H., Su, B.-W., Bao, Y.-N., Wang, W.-H., Lao, J.-Y., Ji, H.-Y., Han, S., Cui, X.-H., Ren, H.-W., & Luan, Z.-L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1880374 · Cited by 1
“The BBB strictly regulates the passage of substances between the blood and brain tissue (Montagne et al., 2017); the tightly junctional endothelial cells of the cerebral microvasculature, the basement membrane, and the astrocyte processes collectively form its structural barrier.”
Bajić, D., Vučković, J., Pupovac, N., Slavić, D., Stojsic, M., Hodoba, N., Todorović, N., Plazačić, M., & Milosevic, N. P. (2026) · Medical Sciences · doi:10.3390/medsci14050536 · Cited by 1
Hemodynamics in Alzheimer’s Disease and Vascular Cognitive Impairment and Dementia
Cambronero, F. E., & Jefferson, A. L. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0014 · Cited by 2
The relationship between the blood-brain barrier, degenerative neuropathy, and oxidative stress
Fisher, D., & Alamu, O. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817780-8.00002-5 · Cited by 1
Губіна-Вакулик, Г. І., & Zorenko, Y. M. (2021) · Morphologia · doi:10.26641/1997-9665.2021.3.66-75 · Cited by 1
Evaluation of F3S4-m loaded liposomes as anti-AChE and its cytotoxic activity in PC12 and HMC3 cells
Camarillo-López, R. H., Morales, L. G. F., Cárdenas, L. F. D., Rivera-Antonio, A. M., Téllez, M. D. L. L. C., Macías, J. I. S., Valdez, M. O., & Rosales‐Hernández, M. C. (2023) · SN Applied Sciences · doi:10.1007/s42452-023-05583-6 · Cited by 1
“Therefore, it is difficult to predict how all this changes in the BBB going to affect the delivery of each drug to the brain [6–9].”
BackgroundBlood brain barrier and its significance in drug delivery to brain in Alzheimer disease
Rana, D., Salave, S., Khunt, D., & Benival, D. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00018-2 · Cited by 2
Rizk, M. Z., & Aly, H. F. (2021) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_36_21 · Cited by 1
Three Neurodegenerative Diseases: A Single Hope
Youssef, S. H., Atalah, H. N., Badawy, M. T., El‐Fawal, H. A. N., & Salama, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_3 · Cited by 3
Daneman, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735754089.793561303 · Cited by 1
Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease
Donepudi, K., Eadha, S., Rodarte, D., Sharma, B., & Kumar, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103211
INVESTIGATING THE ROLE OF VASCULAR ACTIVATION IN ALZHEIMER’S DISEASE-RELATED NEUROINFLAMMATION
Iannucci, J. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/iannucci-jaclyn-2020
Roles of plasminogen activator-plasmin system in nerve system: from physiology to pathology
Kawashita, E. (2020) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.31.381
Brain susceptibility to hypoxia/hypoxemia and metabolic dysfunction in Alzheimer's disease
Baldassarro, V. A., Bighinati, A., Sannia, M., Giardino, L., & Calzà, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00026-8
Santa-Maria, A. R. (2021) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10751
Neelaveni, J., Devasena, M. S. G., & Gopu, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822271-3.00002-5
Hirai, S. (2021) · The Brain & Neural Networks · doi:10.3902/jnns.28.93
Metadata
- Authors
- Montagne, A., Zhao, Z., & Zlokovic, B. V.
- Affiliations
- University of Southern California (US)
- Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, CA 1
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-10-23
- Volume
- 214
- Issue
- 11
- Pages
- 3151-3169
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5679168
- OpenAlex
- W2766949297
- Cited by
- 672
- References
- 200
- Citations by year
- 2026: 54 · 2025: 56 · 2024: 93 · 2023: 82 · 2022: 82 · 2021: 90 · 2020: 91 · 2019: 76 · 2018: 46 · 2017: 2
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01AG023084, R01NS090904, R01NS034467, R01AG039452, 5P01AG052350)
- Cure for Alzheimer’s Fund
- Alzheimer’s Association
- Fondation Leducq (16 CVD 05)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- Alzheimer's disease, blood-brain barrier dysfunction, blood-brain barrier disruption, neurodegeneration, amyloid precursor protein, presenilin 1, tau mutations, apolipoprotein E, transgenic mouse model, BBB repair
- MeSH terms
- Alzheimer Disease, Animals, Blood-Brain Barrier, Disease Models, Animal, Humans, Mice, Transgenic, Mutation, Amyloid beta-Protein Precursor, tau Proteins, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.